Security key
03879J100
Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 197,420,670
- Total 13F shares
- 21,915,953
- Share change
- -1,762,612
- Total reported value
- $77,813,914
- Put/Call ratio
- 141%
- Price per share
- $3.55
- Number of holders
- 72
- Value change
- -$4,704,362
- Number of buys
- 47
- Number of sells
- 21
Report period
Q4 2020
Institutions
72
Top holders
10
ABUS full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Arbutus Biopharma Corp SEC filings
Arbutus Biopharma Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03879J100
Recent filing periods:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3%
|
5,978,355
|
$18,712,000 | — | 30 Sep 2020 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
1.7%
|
3,332,616
|
$10,431,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
2,909,716
|
$9,107,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
2,240,898
|
$7,015,000 | — | 30 Sep 2020 | |
| Think Investments LP |
13F
|
Company |
1%
|
2,000,000
|
$6,260,000 | — | 30 Sep 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.69%
|
1,360,289
|
$4,258,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.53%
|
1,045,394
|
$3,273,000 | — | 30 Sep 2020 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.36%
|
710,000
|
$2,222,000 | — | 30 Sep 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
655,499
|
$2,052,000 | — | 30 Sep 2020 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.25%
|
500,000
|
$1,565,000 | — | 30 Sep 2020 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.24%
|
472,649
|
$1,479,000 | — | 30 Sep 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.21%
|
406,015
|
$1,246,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
380,377
|
$1,190,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
254,115
|
$795,000 | — | 30 Sep 2020 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.13%
|
250,000
|
$766,000 | — | 30 Sep 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
199,938
|
$626,000 | — | 30 Sep 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
127,785
|
$400,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.06%
|
125,300
|
$392,000 | — | 30 Sep 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
119,683
|
$375,000 | — | 30 Sep 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.06%
|
115,000
|
$360,000 | — | 30 Sep 2020 | |
| LMR Partners LLP |
13F
|
Company |
0.05%
|
107,912
|
$338,000 | — | 30 Sep 2020 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
73,561
|
$230,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
70,103
|
$219,000 | — | 30 Sep 2020 | |
| MIRABELLA FINANCIAL SERVICES LLP |
13F
|
Company |
0.03%
|
52,892
|
$166,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
51,910
|
$162,000 | — | 30 Sep 2020 | |
| CADENCE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
50,736
|
$159,000 | — | 30 Sep 2020 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.02%
|
45,373
|
$144,000 | — | 30 Sep 2020 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
45,000
|
$141,000 | — | 30 Sep 2020 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.02%
|
44,362
|
$139,000 | — | 30 Sep 2020 | |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ |
13F
|
Company |
0.02%
|
41,700
|
$131,000 | — | 30 Sep 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
41,074
|
$129,000 | — | 30 Sep 2020 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
39,900
|
$125,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
32,912
|
$104,000 | — | 30 Sep 2020 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.01%
|
29,600
|
$93,000 | — | 30 Sep 2020 | |
| CSS LLC/IL |
13F
|
Company |
0.01%
|
26,700
|
$84,000 | — | 30 Sep 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.01%
|
24,100
|
$75,000 | — | 30 Sep 2020 | |
| Bayesian Capital Management, LP |
13F
|
Company |
0.01%
|
20,600
|
$64,000 | — | 30 Sep 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
17,737
|
$56,000 | — | 30 Sep 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
16,825
|
$53,000 | — | 30 Sep 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
13,879
|
$43,000 | — | 30 Sep 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
13,218
|
$41,000 | — | 30 Sep 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
12,944
|
$41,000 | — | 30 Sep 2020 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.01%
|
11,821
|
$37,000 | — | 30 Sep 2020 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0.01%
|
10,000
|
$31,000 | — | 30 Sep 2020 | |
| Secure Asset Management, LLC |
13F
|
Company |
0.01%
|
10,000
|
$31,000 | — | 30 Sep 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
8,546
|
$27,000 | — | 30 Sep 2020 | |
| Valeo Financial Advisors, LLC |
13F
|
Company |
0%
|
8,000
|
$25,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
7,013
|
$22,000 | — | 30 Sep 2020 | |
| SG3 Management, LLC |
13F
|
Company |
0%
|
5,464
|
$17,000 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
5,336
|
$16,000 | — | 30 Sep 2020 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2020
As of 31 Dec 2020,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,915,953 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, VANGUARD GROUP INC, Think Investments LP, BlackRock Inc., MORGAN STANLEY, ADVISOR GROUP HOLDINGS, INC., Charles Winkler, AMERIPRISE FINANCIAL INC, PRIMECAP MANAGEMENT CO/CA/, and COWEN AND COMPANY, LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
60
Q4 2020 holders
72
Holder diff
12
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.